The reason for the resistance to folate-related antimetabolites is seen in thymidylate synthase (TYMS), whose overexpression has been observed in several solid tumors, including tumors associated with breast cancer, colorectal cancer and mesothelioma [3,4,5]. Here, TYMS is linked to breast cancer.